Login
Toggle navigation
Videos
Categories
Trending
Crypto currencies is Beyond Innovation|Michael Wu,Founder and CEO,Amber Group
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Michael Wu is the Co-Founder and CEO of Amber Group.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
leading investments in transformative companies building in future|Paul Hsiao,General Partner,Canvas Ventures
00:10:00
Unlocking Investment Potential: Oreninc at 121 Mining Investment New York 2018
00:10:00
Jim Cramer interviews Pegasystems CEO Alan Trefler about the company's growth post-transition to cloud services and future expansion plans.
00:10:00
Champion Chats: Arch Resources | Paul A Lang, CEO, Arch Resources IncARCH:NYQ
00:10:00
Investing in Global Feeder Funds: Insights on ATRAM’s Global Technology Feeder Fund
00:10:00
Power Dynamics: Interview with Aboitiz Power President & CEO | Manny Rubio , CEO, Aboitiz Power Corp.
00:10:00
Simplifying Options for Consumers in the Clean Energy Future | Jeffrey B. Guldner, CEO , Arizona Public Service.
00:10:00
Maxime Brossard: From Finance to Family Business Leadership and Sustainability | Maxime Séché, Managing Director ,Seche Environnement SA.
00:10:00
Securing Your First $1M Startup Investment|Allison Pickens,Founder and General Partner,The New Normal Fund
00:10:00
Metals Australia Advances Lac Rainy Graphite Project
00:10:00
Oryx Geoscience: Integrating Historical Data with Modern Exploration for Mining Success
00:10:00
Launching Mobile Backgammon Game with Real-Time Voice and Video Integration Aims to Boost User Engagement and Subscriptions | Jason Katz, CEO, Paltalk Inc.